| Document Date: 2012-09-14 13:42:34
Open Document File Size: 226,66 KBShare Result on Facebook
City Dunn / Lexington / / Company Kits / CVS/Caremark / Ancillary Supplies / GE / / Event FDA Phase / / Facility Specialty Pharmacy / The American College of Obstetricians / / / IndustryTerm limited distribution network / injectable products / injectable product / / MedicalCondition bronchopulmonary dysplasia / PDA / Respiratory Syncytial Virus Infections / significant Congenital Heart Disease / congestive heart failure / cardiomyopathy / CHD / upper respiratory infections / RSV infection / Patent ductus arteriosus / Moderate-Severe Pulmonary Hypertension / chronic / cyanotic heart disease / significant congenital abnormality / heart disease / Chronic corticosteroid therapy / bronchiolitis / Congenital Abnormality / lung disease / hemodynamically significant congenital heart disease / severe combined immunodeficiency syndrome / AIDS / Infectious Diseases / breakthrough RSV infection / cystic fibrosis / MS / influenza / List Allergies / severe pulmonary hypertension / syndrome / croup / chronic bronchitis / respiratory distress / recurrent upper respiratory infections / asthma / / MedicalTreatment bypass / heart surgery / positive pressure ventilation / / Organization Kentucky Spirit Health Plan Pharmacy Department / Kentucky Spirit / The American College / American Academy of Pediatrics / / Person Jeremy Corbett / / / Position Medical Director / nurse / / Product Synagis / Epinephrine / Previous injections / Synagis® / / ProvinceOrState Kentucky / Mississippi / / Technology PDA / /
SocialTag |
Kentucky Spirit Health Plan 1019 Majestic Drive, Suite 260 Lexington, Kentucky[removed]Phone[removed]Respiratory Syncytial Virus (RSV) Season and Synagis® Criteria August 2012